Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Expert review of vaccines - 21(2022), 11 vom: 13. Nov., Seite 1533-1535 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stepanova, Ekaterina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bivalent vaccine |
|---|
| Anmerkungen: |
Date Completed 25.10.2022 Date Revised 15.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14760584.2022.2117692 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345230035 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345230035 | ||
| 003 | DE-627 | ||
| 005 | 20231226024606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14760584.2022.2117692 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1150.xml |
| 035 | |a (DE-627)NLM345230035 | ||
| 035 | |a (NLM)36004567 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stepanova, Ekaterina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.10.2022 | ||
| 500 | |a Date Revised 15.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Influenza | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a bivalent vaccine | |
| 650 | 4 | |a coinfection | |
| 650 | 4 | |a viral vectored vaccine | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines, Combined |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 700 | 1 | |a Isakova-Sivak, Irina |e verfasserin |4 aut | |
| 700 | 1 | |a Rudenko, Larisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of vaccines |d 2002 |g 21(2022), 11 vom: 13. Nov., Seite 1533-1535 |w (DE-627)NLM126545200 |x 1744-8395 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2022 |g number:11 |g day:13 |g month:11 |g pages:1533-1535 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2022.2117692 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2022 |e 11 |b 13 |c 11 |h 1533-1535 | ||